NCT05829239View on ClinicalTrials.gov

ADI-PEG20, Obesity and Prediabetes

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2024

Study Completion Date

May 1, 2024

Conditions
ObesityPreDiabetes
Interventions
BIOLOGICAL

ADI-PEG20

Intramuscular injection weekly for 8 weeks

OTHER

Placebo

Intramuscular injection weekly for 8 weeks

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors
All Listed Sponsors
collaborator

Children's Discovery Institute

OTHER

collaborator

Polaris Pharmaceuticals, Inc.

UNKNOWN

lead

Washington University School of Medicine

OTHER